Nurix Therapeutics (NRIX) Q2 2026 Earnings

Apr 8Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.03
-0.86
-0.69
-0.52

Details

Expected EPS
-0.762556
Actual EPS
-0.79
Surprise EPS
-0.03
Surprise Percent
-3.6%

Description

⁨Nurix Therapeutics⁩ (⁦NRIX⁩) has reported earnings of ⁦-0.79⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts